Perri, Maria Teresa
 Distribuzione geografica
Continente #
NA - Nord America 110
EU - Europa 94
AS - Asia 56
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 262
Nazione #
US - Stati Uniti d'America 110
IT - Italia 29
SG - Singapore 25
CN - Cina 15
IE - Irlanda 15
DE - Germania 13
FI - Finlandia 10
SE - Svezia 10
ID - Indonesia 8
FR - Francia 4
KR - Corea 4
IN - India 3
NL - Olanda 3
RU - Federazione Russa 3
GB - Regno Unito 2
MK - Macedonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BR - Brasile 1
HU - Ungheria 1
LT - Lituania 1
TW - Taiwan 1
Totale 262
Città #
Ashburn 25
Singapore 20
Chandler 15
Dublin 15
Helsinki 9
Rome 9
Jakarta 8
New York 6
Milan 5
Munich 5
New Haven 4
Washington 4
Amsterdam 3
Beijing 3
Boston 3
Busto Arsizio 3
Jeju City 3
Wilmington 3
Bari 2
Erie 2
Falkenstein 2
Los Angeles 2
Moscow 2
Nave 2
Paris 2
Princeton 2
San Mateo 2
Antwerp 1
Asti 1
Bremen 1
Budapest 1
Cagliari 1
Dearborn 1
Guidonia Montecelio 1
Hebei 1
Jacksonville 1
Lappeenranta 1
Marseille 1
Mountain View 1
Nanjing 1
Ningbo 1
Portland 1
Puyang Chengguanzhen 1
San Francisco 1
Santa Clara 1
Suyeong-gu 1
São Paulo 1
Taipei 1
Tappahannock 1
Vienna 1
Totale 184
Nome #
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 55
Immunotherapy-related imaging findings in patients with gynecological malignancies: What radiologists need to know 47
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 38
Recent progress in the use of pharmacotherapy for endometrial cancer 29
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 27
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 24
Advanced and recurrent endometrial cancer: State of the art and future perspectives 22
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 17
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 13
Totale 272
Categoria #
all - tutte 2.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 2 0 0 0 2 0
2020/20212 0 0 0 0 0 1 0 0 0 0 1 0
2021/202213 0 0 0 1 0 0 0 4 0 1 3 4
2022/202374 6 6 1 7 2 7 2 1 11 7 18 6
2023/2024117 2 22 14 11 6 15 16 1 4 3 13 10
2024/202555 6 1 23 3 13 9 0 0 0 0 0 0
Totale 272